Video - The interest of automated testing for all four CSF biomarkers

Nov 18, 2021

Automated testing for the four main cerebrospinal fluid (CSF) biomarkers to help with early and reliable Alzheimer's disease diagnosis is possible today.

In less than 2 minutes, this video explains the advantages of automated biomarker testing for all four CSF biomarkers.

If you want to understand the particular clinical interest of referring to the Aβ1-42/Aβ1-40 ratio to improve accuracy of Alzheimer's disease diagnosis we recommend you also view this video, or you can also contact us, of course.   :-) 

 

 

Subscribe to Fujirebio insight updates

Get all the latest insight articles from Fujirebio the moment they are published.

The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

Related articles

Related products

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.